Sphingosine-1-phosphate (SPP) was initially described as an intermediate in the metabolic pathway of long-chain sphingoid bases1). However, it is now widely accepted as a unique bioactive lipid messenger. It acts as a second messenger to regulate proliferation and survival intracellularly, and as a ligand for G protein-coupled receptors of the EDG-1 subfamily extracellularly2-4). SPP is involved in a variety of cellular functions, including mediated neuronal survival and differentiation9), regulation of cell motility10,11), platelet activation12), activation of muscarinic K+ currents13), neurite retraction14) airway remodeling in asthma15), and cell proliferation, especially in signal transduction pathways of platelet-derived growth factor (PDGF) 16 We previously screened for inhibitors of SPH kinase and isolated novel SPH kinase inhibitors F-12509A20) and B-5354c21,22) from microbial metabolites. F-12509A was isolated from a culture broth of a discomycete, Trichopezizella barbata SANK 25395. The structure of F-12509A is a new sesquiterpene quinone consisting of a drimane moiety and a dihydroxybenzoquinone (Fig. 1) . B5354c was isolated from a culture broth of a novel marine bacterium, SANK 71896. The structure of B-5354c is a new ester of 4-amino-3-hydroxybenzoic acid with a longchain unsaturated alcohol (Fig. 1 The inhibitory effects of F-12509A and B-5354c on recombinant human SPH kinase isoforms were compared with N,N-dimethylsphingosine (DMS, Fig. 1 (Fig. 3A) . Thus, F-12509A inhibited both human SPH kinase isoforms competitively with respect to SPH. This result suggests that the sesquiterpene moiety of F-12509A may mimic the conformation of SPH binding the active sites of SPH kinase isoforms. On the other hand, B-5354c decreased the apparent Vmax values, while the Km values for SPH remained unaltered (Fig. 3B) . Thus, B-5354c showed noncompetitive-type inhibition with respect to SPH. This result suggests that B-5354c may interact with domains distinct from the SPH binding sites and regulate SPH kinase activity. It was reported previously that when using inactive derivatives of B-5354c, the double bond in the aliphatic chain of B-5354c is important for its inhibitory activity22). Interestingly, phosphatidylserine stimulates the activities of both SPH kinase isoforms in a noncompetitive manner and the lipid also needs double bonds in its aliphatic chain to regulate SPH kinase activity19,24). These findings raise the possibility that B-5354c modulates SPH kinase activity by a similar mechanism to phosphatidylserine.
In addition, DMS inhibited hSPHK1 competitively, whereas it inhibited hSPHK2 noncompetitively (Fig. 3C) , both results being similar to those of murine SPH kinase isoforms reported previously17, 19) The Ki values of these inhibitors are shown in Table 1 . Comparing the Ki values, inhibitory potencies of F-12059A and B-5354c for SPH kinase activities in cytosol from HEK293 cells transfected with hSPHK1 (1) and hSPHK2 (2) 
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The KI values of recombinant hSPHK1 (1) and hSPHK2 (2) for F-12509A, B-5354c and DMS were calculated from the Lineweaver-Burk plots shown in Fig. 3 .
